Education Students Posters Resources Engage Destination Supporters #BeThe1To

Registration Options

Activity Date: 04/09/2019

Session Time and Location

The live session is complete.

Target Audience

This course is designed for pharmacists, nurse practitioners or other health care professionals involved in the comprehensive medication management of psychiatric and/or neurological patients.

Session Summary

With the revisions to the DSM-5 as well as the recent focus on under-recognition and potential for increased mortality, the pharmacist needs to be competent in recognizing catatonia. Furthermore the psychiatric pharmacist needs to understand common rating scales to detect and measure severity of catatonic symptoms. It is also critical for any clinician treating patients with catatonia to note differences among malignant catatonia, NMS, and malignant hyperthermia since many symptoms overlap.

Also in this session, we will review common treatments for catatonia along with reviewing the evidence for common second and third line agents should the patient not respond or not have access to the usual first line treatments such as benzodiazepines and ECT.

Course Requirements

To receive ACPE credit for the live session at the Annual Meeting, you must:

  • Sign in (or create a FREE account).
  • Register for this course.
  • Attend and participate in the entire session and reflect upon its teachings.
  • Complete the evaluation at the end of the activity.
  • Provide the necessary details in your profile to ensure correct reporting by CPNP to CPE Monitor.

This course will be provided at the CPNP 2019 Annual Meeting, April 7-10, 2019. Upon successful completion, ACPE credit is reported immediately to CPE Monitor although transcripts can be retrieved by participants online at

Faculty Information and Disclosures

Christopher Thomas PharmD, BCPP, BCPS

View biographical information and disclosures

Learning Objectives

  1. Recognize symptoms, common rating scales, and complications of catatonia
  2. Examine the role of pharmacotherapy and ECT in catatonia,
  3. Compare and contrast the evidence to support novel treatment strategies for the management of catatonia.
  4. Develop a treatment plan for someone with the diagnosis of catatonia.

Continuing Education Credit and Disclosures

Activity Date: 04/09/2019
ACPE Contact Hours: 1
ACPE Number: 0284-0000-19-032-L04-P (Knowledge)
Nursing Credit Reminder: Note that ACPE credit is accepted for certification renewal.

ACPEThe College of Psychiatric and Neurologic Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This course provides 1.0 contact hour of knowledge-based continuing education credit from CPNP approved programming.

25 Years!